Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,475,406 papers from all fields of science
Search
Sign In
Create Free Account
MIR17 gene
Known as:
miRNA91
, microRNA 17
, MIR17-5p
Expand
This gene is involved in the regulation of gene expression and plays an oncogenic role in hepatocellular, lung, colorectal, thyoid and breast…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
Breast Carcinoma
Carcinoma of lung
Colorectal Carcinoma
Homo sapiens
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
miRNA-31 regulates the CD8 T cell response to type I IFNs during chronic infection
M. Catálfamo
Cellular & Molecular Immunology
2017
Corpus ID: 44328813
2017
2017
miRNA-17-3 / 5 p in prostate cancer tissues predicts clinical characteristics and is associated with PTEN
Tao Li
,
S. Feng
,
Xiaosong Qian
,
Mulan Jin
,
Xu-hui Zhu
,
Xiaodong Zhang
2017
Corpus ID: 264777156
Prostate cancer is a common malignant tumor in men. Current diagnostic markers do not accurately reflect the progression and risk…
Expand
2015
2015
Preliminary Study: Prominent miRNAs of Breast Malignant Tissues Compared to Normal Tissues in Turkish Patients with Breast Cancer.
T. Ozturk
,
O. Kucukhuseyin
,
+11 authors
Turgar Isbir
Anticancer Research
2015
Corpus ID: 6225084
miRNA involvement has been observed in almost every type of cancer, including breast cancer. The etiology of abnormal expression…
Expand
2008
2008
MicroRNAs and lymphocyte homeostasis: Dangerous eggs in a single basket
D. Merino
,
P. Bouillet
Immunology and Cell Biology
2008
Corpus ID: 19317166
The critical role of the BH3-only proapoptotic protein Bim in hematopoietic homeostasis and as a barrier against autoimmunity is…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE